Published in Cancer Invest on February 01, 2007
Steroid hormone transforming aldo-keto reductases and cancer. Ann N Y Acad Sci (2009) 1.41
Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2. Mol Cancer Ther (2009) 1.02
Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness. Oncogene (2010) 0.97
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for intervention. Front Oncol (2014) 0.95
Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy. Int J Clin Oncol (2012) 0.91
Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology. Prostate Cancer (2012) 0.90
High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions. Assay Drug Dev Technol (2014) 0.77
Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen. BMC Cancer (2016) 0.75
Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen. Assay Drug Dev Technol (2016) 0.75
Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth. Cancer Res (2015) 0.75
Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab (2007) 3.43
Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. J Urol (2009) 3.01
Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest (2004) 1.88
ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat Med (2007) 1.87
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res (2007) 1.79
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate (2006) 1.78
Industry-based retrospective cohort study of the risk of prostate cancer among rotating-shift workers. Int J Urol (2011) 1.67
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli. Int J Antimicrob Agents (2010) 1.67
Infrared fluorescence endoscopy for the diagnosis of superficial gastric tumors. Gastrointest Endosc (2007) 1.63
Development of a novel PCR method to comprehensively analyze salivary bacterial flora and its application to patients with odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.60
Retrospective cohort study of the risk of obesity among shift workers: findings from the Industry-based Shift Workers' Health study, Japan. Occup Environ Med (2010) 1.60
Application of RNA polymerase beta-subunit gene (rpoB) sequences for the molecular differentiation of Legionella species. J Clin Microbiol (2002) 1.59
The human apoptosis inhibitor NAIP induces pyroptosis in macrophages infected with Legionella pneumophila. Microbes Infect (2012) 1.49
Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat Med (2004) 1.48
European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents (2007) 1.48
Differential diagnosis between bacterial infection and neoplastic fever in patients with advanced urological cancer: the role of procalcitonin. Int J Urol (2013) 1.44
Central control of fever and female body temperature by RANKL/RANK. Nature (2009) 1.42
Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade. J Urol (2008) 1.41
Japan Cancer of the Prostate Risk Assessment for combined androgen blockade including bicalutamide: clinical application and validation. Int J Urol (2012) 1.40
Female urology: what method will you select? Int J Urol (2009) 1.39
Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis (2010) 1.39
Nationwide survey of urogenital tuberculosis in Japan. Int J Urol (2014) 1.38
Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res (2008) 1.34
Shematrin: a family of glycine-rich structural proteins in the shell of the pearl oyster Pinctada fucata. Comp Biochem Physiol B Biochem Mol Biol (2006) 1.29
ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors. Neoplasia (2012) 1.28
The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines. Prostate (2007) 1.27
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin Exp Metastasis (2008) 1.25
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation. EMBO Mol Med (2013) 1.23
Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation. Cancer Res (2008) 1.22
Lumbar instability and clinical symptoms: which is the more critical factor for symptoms: sagittal translation or segment angulation? J Spinal Disord Tech (2004) 1.22
Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci U S A (2005) 1.22
Acute pyogenic sacroiliitis without predisposing conditions. Spine (Phila Pa 1976) (2003) 1.21
Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling. Cancer Res (2013) 1.20
REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy. CNS Neurosci Ther (2010) 1.19
Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Cancer Res (2004) 1.19
Androgen deprivation therapy for prostate cancer. Expert Opin Pharmacother (2008) 1.19
Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction. J Urol (2010) 1.17
The role of the androgen receptor in the development and progression of bladder cancer. Jpn J Clin Oncol (2012) 1.16
Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor. Am J Pathol (2013) 1.16
Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol (2004) 1.15
Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int (2010) 1.15
Bacterial resistance to antimicrobials in urinary isolates. Int J Antimicrob Agents (2004) 1.15
Tyrosinase localization in mollusc shells. Comp Biochem Physiol B Biochem Mol Biol (2006) 1.14
High correlation between the bacterial species in denture plaque and pharyngeal microflora. Gerodontology (2003) 1.14
PKClambda regulates glucose-induced insulin secretion through modulation of gene expression in pancreatic beta cells. J Clin Invest (2005) 1.12
Cyclooxygenase-2 promotes prostate cancer progression. Prostate (2002) 1.12
YB-1 is important for an early stage embryonic development: neural tube formation and cell proliferation. J Biol Chem (2006) 1.12
Effect of ER-beta gene disruption on estrogenic regulation of anxiety in female mice. Physiol Behav (2008) 1.12
Increased expression of a Myc target gene Mina53 in human colon cancer. Am J Pathol (2004) 1.10
Androgen receptor roles in the development of benign prostate hyperplasia. Am J Pathol (2013) 1.10
Formaldehyde exposure in a gross anatomy laboratory--personal exposure level is higher than indoor concentration. Environ Sci Pollut Res Int (2006) 1.09
Chaos of vowel /a/ in Japanese patients with depression: a preliminary study. J Occup Health (2005) 1.09
Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1. BMC Urol (2008) 1.08
Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications. Clin Cancer Res (2004) 1.08
A novel nacre protein N19 in the pearl oyster Pinctada fucata. Biochem Biophys Res Commun (2007) 1.08
Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Mol Carcinog (2011) 1.07
Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study. Aging Male (2010) 1.06
Androgen activates β-catenin signaling in bladder cancer cells. Endocr Relat Cancer (2013) 1.06
Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns. J Clin Microbiol (2009) 1.05
Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol (2009) 1.05
Frozen section assessment in testicular and paratesticular lesions suspicious for malignancy: its role in preventing unnecessary orchiectomy. Hum Pathol (2012) 1.05
Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res (2003) 1.05
Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth. Mol Endocrinol (2006) 1.04
PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro. Int J Cancer (2007) 1.03
Centrally and peripherally administered ghrelin potently inhibits water intake in rats. Endocrinology (2007) 1.03
Cranial nerve deficit caused by skull metastasis of prostate cancer: three Japanese castration-resistant prostate cancer cases. Int J Clin Oncol (2010) 1.02
Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J (2005) 1.02
Colorectal xanthomas with polypoid lesion: report of 25 cases. APMIS (2004) 1.01
Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae. Int J Antimicrob Agents (2006) 1.01
Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells. Proc Natl Acad Sci U S A (2003) 1.01
Matrix metalloproteinase-12 gene expression in human vascular smooth muscle cells. Genes Cells (2003) 1.01
Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 1.01
The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer. Cancer Res (2005) 1.01
Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis. Antimicrob Agents Chemother (2005) 1.01
Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases. Am J Surg Pathol (2010) 1.01
FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway. PLoS One (2012) 0.99
Contrary regulation of bladder cancer cell proliferation and invasion by dexamethasone-mediated glucocorticoid receptor signals. Mol Cancer Ther (2012) 0.99
A role of aryl hydrocarbon receptor in the antiandrogenic effects of polycyclic aromatic hydrocarbons in LNCaP human prostate carcinoma cells. Arch Toxicol (2003) 0.98
Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells. Endocr Relat Cancer (2011) 0.98
Synchronized bursts of miniature inhibitory postsynaptic currents. J Physiol (2010) 0.98
Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor. Clin Exp Metastasis (2004) 0.98
A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker. Cancer Chemother Pharmacol (2013) 0.97
Etiological role of human papillomavirus infection for inverted papilloma of the bladder. J Med Virol (2011) 0.97
Prognostic factors for deterioration of patients with cervical spondylotic myelopathy after nonsurgical treatment. Spine (Phila Pa 1976) (2007) 0.97
Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy. Spine (Phila Pa 1976) (2006) 0.96
GABA is excitatory in adult vasopressinergic neuroendocrine cells. J Neurosci (2012) 0.96
Clinical outcomes and predictive factors relating to prognosis of conservative and surgical treatments for cervical spondylotic amyotrophy. Spine (Phila Pa 1976) (2011) 0.96
Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion. Int J Clin Oncol (2008) 0.95
Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor. Int J Oncol (2012) 0.95
Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents (2008) 0.95
Clinical and radiological outcome of surgery for pyogenic and tuberculous spondylitis: comparisons of surgical techniques and disease types. J Neurosurg Spine (2009) 0.95
Antibiotic susceptibility of glutaraldehyde-tolerant Mycobacterium chelonae from bronchoscope washing machines. Am J Infect Control (2004) 0.95
Pharmacological aspects of the effects of tramadol on G-protein coupled receptors. J Pharmacol Sci (2007) 0.94
N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men. Int J Urol (2003) 0.94
The prognosis of conservative treatments for lumbar spinal stenosis: analysis of patients over 70 years of age. Spine (Phila Pa 1976) (2005) 0.94
Endogenous prolactin-releasing peptide regulates food intake in rodents. J Clin Invest (2008) 0.93
Hormonal therapy. Int J Clin Oncol (2007) 0.93
Expression of human AR cDNA driven by its own promoter results in mild promotion, but not suppression, of growth in human prostate cancer PC-3 cells. Asian J Androl (2007) 0.93